| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |